Possible reduction of effective thickness of intestinal unstirred water layer by particle drifting effect

被引:71
作者
Sugano, Kiyohiko [1 ]
机构
[1] Pfizer Inc, Global Res & Dev, Sandwich Labs, Res Formulat, Sandwich CT13 9NJ, Kent, England
关键词
Oral absorption; Particle size; Unstirred water layer; Permeability; ORAL-DRUG ABSORPTION; MINISCALE DISSOLUTION TEST; IN-VIVO; COMPUTER-SIMULATION; ADMINISTERED DRUGS; SIZE REDUCTION; SOLUBLE DRUGS; BEAGLE DOGS; MODEL; PERMEABILITY;
D O I
10.1016/j.ijpharm.2009.12.014
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
According to the present theory of oral absorption, in the case of solubility limited absorption, the absorbed amount would not increase despite an increase in dose or a decrease in particle size. However, many experimental observations suggested that the absorbed amount was often increased (though sub-proportionally) as the dose strength increased. In addition, the particle size reduction was often effective to increase the absorbed amount even in the case of solubility limited absorption. Since an increase of the dose strength and a decrease of the particle size cause no or little change in solubility and the mean intestinal transit time, effective intestinal membrane permeability (P(eff)) should have changed. The previous theory postulated that drug particles do not exist in the unstirred water layer (UWL) which is adjacent to the intestinal membrane. However, many reports suggested that nano- to micro-scale drug particles existed in the UWL In this case, the effective thickness of the UWL (h(eff)) could be smaller than the nominal thickness, resulting in an increase of P(eff). In the present study, h(eff) was simply calculated assuming that the reduction of h(eff) is in proportion to the surface area of drug particles in the UWL When the particle drifting effect was taken into account, the discrepancy between the theoretical calculation and experimental observations Was reduced. It was suggested that when the dose (mg)/particle diameter (mu m) ratio exceeds 20, the particle drifting effect would become significant. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:103 / 109
页数:7
相关论文
共 49 条
[1]   Relative bioavailability of griseofulvin lyophilized dry emulsion tablet vs. immediate release tablet: A single-dose, randomized, open-label, six-period, crossover study in healthy adult volunteers in the fasted and fed states [J].
Ahmed, Iman Saad ;
Aboul-Einien, Mona Hassan ;
Mohamed, Osama Hussein ;
Farid, Samar Farghali .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 35 (03) :219-225
[2]   Gastroduodenal mucus bicarbonate barrier:: protection against acid and pepsin [J].
Allen, A ;
Flemström, G .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2005, 288 (01) :C1-C19
[3]   THEORETICAL AND EXPERIMENTAL STUDIES OF TRANSPORT OF MICELLE-SOLUBILIZED SOLUTES [J].
AMIDON, GE ;
HIGUCHI, WI ;
HO, NFH .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1982, 71 (01) :77-84
[4]   The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo [J].
Atuma, C ;
Strugala, V ;
Allen, A ;
Holm, L .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2001, 280 (05) :G922-G929
[5]  
Avdeef A., 2006, PHARMACOKINETIC PROF
[6]  
Avdeef A., 2003, ABSORPTION DRUG DEV
[7]   The single and multiple dose pharmacokinetics of pranlukast in healthy volunteers [J].
Brocks, DR ;
Upward, JW ;
Georgiou, P ;
Stelman, G ;
Doyle, E ;
Allen, E ;
Wyld, P ;
Dennis, MJ .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 51 (3-4) :303-308
[8]   ABSORPTION CHARACTERISTICS OF SOLID DISPERSED AND MICRONIZED GRISEOFULVIN IN MAN [J].
CHIOU, WL ;
RIEGELMAN, S .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1971, 60 (09) :1376-+
[9]   Gastrointestinal uptake of biodegradable microparticles: Effect of particle size [J].
Desai, MP ;
Labhasetwar, V ;
Amidon, GL ;
Levy, RJ .
PHARMACEUTICAL RESEARCH, 1996, 13 (12) :1838-1845
[10]   Factors influencing intestinal microparticle uptake in vivo [J].
Doyle-McCullough, M. ;
Smyth, S. H. ;
Moyes, S. M. ;
Carr, K. E. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 335 (1-2) :79-89